(Q33852836)

29 July 2017

1 reference

title

The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema (English)

1 reference

29 July 2017

Craig James Beavers

1

1 reference

29 July 2017

Steven P Dunn

series ordinal

2

1 reference

29 July 2017

Tracy E Macaulay

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

22 March 2011

1 reference

Annals of Pharmacotherapy

29 July 2017

1 reference

29 July 2017

45

1 reference

29 July 2017

4

1 reference

29 July 2017

520-524

1 reference

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

29 July 2017

1 reference

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in coll

21 January 2018

1 reference

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

21 January 2018

1 reference

Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis

21 January 2018

1 reference

Angiotensin receptors and their antagonists

21 January 2018

1 reference

Angioneurotic edema attributed to the use of losartan

21 January 2018

1 reference

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

21 January 2018

1 reference

Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

21 January 2018

1 reference

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

21 January 2018

1 reference

Use of angiotensin receptor blockers after angioedema with an angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

Strengths and limitations of meta-analysis: larger studies may be more reliable

21 January 2018

1 reference

Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1P630

1 reference

29 July 2017

1 reference